Brand recall history

Slate Run Pharmaceuticals recalls

Every FDA recall record we found for Slate Run Pharmaceuticals, newest first. Updated Oct. 11, 2026.

2 recalls since 2025. The most recent was on March 4, 2026.

Last 12 months: 1
Most recent: 2026-03
Most serious (FDA Class I): 0
Last 30 days: 0

Recalls by year

2025–2026

2526

Class I (FDA, most serious)Other recalls

Get recall alerts

We email you when Slate Run Pharmaceuticals has a new recall. Free; one click to stop.

We use your email only for these alerts. Privacy

Recent recalls

1 of 2

March 4, 2026Class IIIFDA · Drug

Eptifibatide Injection…

Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.

Filed by: Slate Run Pharmaceuticals

More recalls

March 26, 2025Cinacalcet Hydrochloride Tablets 30 mg… and 1 more product Class IICGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

How we match: a recall is listed here when the agency names Slate Run Pharmaceuticals as the company that filed it. Sources: FDA enforcement reports and FDA-posted company announcements, CPSC recall notices and NHTSA recall campaigns.

Report a mistake on this page